Real-World Utility of a Non-Invasive Gene Expression Test to Rule Out Primary Cutaneous Melanoma: A Large US Registry Study

摘要

Introduction: The Pigmented Lesion Assay (PLA) is a non-invasive gene expression test that helps clinicians rule out melanoma via a genomics approach that elevates pigmented lesion management beyond what the eye can see. PLA improves care with a negative predictive value of >99% while reducing biopsies by 90% and while reducing cost.